Lenire Tinnitus Treatment Device

17/12/2025

Tobias and Battite Hearing Wellness tinnitus expert, Miles Sabine, joins Talking Tinnitus to discuss what jobs are most at risk of tinnitus and how you can protect your hearing.

"So you’re thinking musicians, construction workers, people who work in a factory or around any heavy equipment, heavy machinery, things like that,” said Dr. Sabine.

You can watch the "What Jobs are Linked to Tinnitus" episode of Talking Tinnitus and read a full article on high-risk professions over on the Lenire Blog.

https://www.lenire.com/category/talking-tinnitus/

15/12/2025

After just three weeks, tinnitus patients are already noticing meaningful changes with Lenire, a treatment designed to be both effective and easy to live with.

Discover how Lenire, the first and only -approved treatment device, is helping people take control of tinnitus.

https://www.lenire.com/resources/patient-stories/

12/12/2025

Stories like this remind us of the hope Lenire can bring to people living with tinnitus.

We’re grateful to the dedicated providers across the U.S. and Europe who help patients reclaim control and find relief.

Want to read more patient experiences? Visit Lenire.com for real stories of real change, https://www.lenire.com/resources/patient-stories/

27/11/2025

Wishing a very Happy Thanksgiving to our friends, family, and colleagues.

At Neuromod Devices, we are especially grateful for our clinical partners and organizations like the American Tinnitus Association, whose work continues to make a real difference for people living with tinnitus across the U.S.

11/11/2025

Lenire would like honor all who served. Your courage and dedication protect the freedoms we cherish. Thank you to our Veterans. Happy Veterans Day.

Tinnitus impacts 3.2 million veterans, making it the #1 service-connected disability. That is why Lenire is proud to support the Hearoes Tour from the The LexCare Hearing Foundation.

The LexCare Hearing Foundation is charitable organization committed to raising awareness, expanding access, and inspiring action for the millions living with untreated hearing loss and tinnitus. We're supporting their mission of bridging the gap between veterans and hearing healthcare professionals.

10/11/2025

10/11/2025

"You can couple hearing and . But you also have to think about uncoupling it for certain patients".

Hearing loss and tinnitus are related but not the same.

Lenire sat down with Dr. Gail Whitelaw from The Ohio State University Dept. of Speech and Hearing Science, one of the world's leading tinnitus experts, to unpack how closely related hearing loss and tinnitus are and how patients can direct their own care.

Watch the full episode of Talking Tinnitus below 👇

22/10/2025

Neuromod is at EUHA 2025 in Nuremberg at Hall 7, Booth 228 — it's hard to miss!

Speak with our team about , the treatment device that is proven in large-scale clinical trials and with real world patients.

Visit the our booth to learn how you can offer your patients proven relief from tinnitus, hear a sample of the Lenire's audio, and find out how you can enrol in Tinnitus Masterclass from Neuromod.

21/10/2025

Lenire by Neuromod is now the highest rated available tinnitus treatment option according to Tinnitus UK's updated treatment information sheets.

Tinnitus UK's update acknowledges the expansive body of clinical trial and real world evidence for Lenire, as well as the seismic shift in attitudes towards bimodal neuromodulation as a tinnitus treatment method.

"Lenire is considered very safe, with clear evidence of effectiveness compared to no treatment – a level of efficacy currently matched only by professional cognitive behavioural therapy (CBT) and hearing aids," writes Tinnitus UK's Laura Hine. "This reflects the growing body of evidence being published that shows the efficacy not just of bimodal neuromodulation, but the Lenire® device specifically."

We're changing our treatment information sheets to better reflect the latest research evidence

21/10/2025

Neuromod Devices is proud to launch Tinnitus Masterclass, an online course that will equip hearing care professionals with the clinical and commercial knowledge to confidently introduce, or expand, tinnitus care at their clinic.

“Demand for tinnitus care from expert clinicians is significant. Building the knowledge and confidence of clinicians interested in helping tinnitus patients is critical to serving the global patient population,” said Dr. Ross O'Neill Ph. D., Neuromod Founding CEO.

“Tinnitus Masterclass delivers this by combining expertise from some of the most experienced tinnitus clinicians practising today with Neuromod’s significant experience training audiology and ENT practices in clear, practical lessons”.

Find out more about Tinnitus Masterclass by visiting Booth 228 (Hall 7) at EUHA 2025. You can also sign up on our Neuromod's website.

Neuromod launches Tinnitus Masterclass, a comprehensive online course that provides clinical and commercial expertise on tinnitus care.

21/10/2025

Neuromod Devices is proud to be part of EUHA in Nuremberg, Germany, from October 22–24.

We look forward to a few inspiring days of collaboration, innovation, and sharing global insights on advancing tinnitus care.

📍 Visit us at Booth #228 (Hall 7) to learn more about , the world’s first and only FDA-approved bimodal neuromodulation device for tinnitus.

17/10/2025

We’re thrilled to see KRDO13 News highlight how , the only FDA-approved bimodal neuromodulation device, is already helping tinnitus patients in 's only southern Colorado provider, Hearing Consultants of Colorado Springs.

The article shares how clinicians like Dr. Cassie Iliff, are using to bring hope to those living with persistent ringing in the ears, combining gentle tongue stimulation with customized sound therapy to help the brain reduce the perception of tinnitus.

COLORADO SPRINGS, Colo. (KRDO) -- There's a new The U.S. Food and Drug Administration (FDA)-approved tinnitus technology that's showing great results